Results 81 to 90 of about 9,966 (258)
Studying synthesis confinement effects on the internal structure of nanogels in computer simulations [PDF]
We study the effects of droplet finite size on the structure of nanogel particles synthesized by random crosslinking of molecular polymers diluted in nanoemulsions.
Kantorovich, Sofia S. +3 more
core +1 more source
Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) [PDF]
Chengwen Teng, Christopher R. Frei
openalex +1 more source
ABSTRACT Background Drug safety has historically been understudied in pediatric populations, rendering them “therapeutic orphans.” Pediatric drug indications and dosages are often inferred by extrapolating safety, efficacy, and dosing data from adult studies, leading to widespread off‐label use.
Saurabh Rahurkar +8 more
wiley +1 more source
Safety of lifitegrast: A real-world pharmacovigilance study based on FAERS
To comprehensively assess the safety of Lifitegrast, a drug for dry eye disease, we conducted a comprehensive analysis of adverse event (AE) reports from the FDA Adverse Event Reporting System (FAERS). This retrospective study examined all AE reports submitted between Q3 2016 and Q2 2024, employing disproportionality analysis to identify safety signals
Chu Zhang +4 more
openaire +3 more sources
Safety analysis of quinolones use in minors—based on the FAERS database
ObjectiveThis study utilizes the FDA Adverse Event Reporting System (FAERS) to investigate adverse drug event (ADE) signals linked to quinolones use (ciprofloxacin, moxifloxacin, levofloxacin, ofloxacin) in minors, offering insights for clinical use.MethodsMinors were categorized into four age groups.
Yanwei Li +5 more
openaire +3 more sources
ObjectiveSapropterin dihydrochloride is the first drug for the therapy of phenylketonuria, which is a rare disease that occurs one of 10,000–15,000 newborns.
Jiahong Zhong, Xihui Yu, Zhuomiao Lin
doaj +1 more source
Concordance and predictive value of two adverse drug event data sets [PDF]
Background: Accurate prediction of adverse drug events (ADEs) is an important means of controlling and reducing drug-related morbidity and mortality.
Cami, Aurel, Reis, Ben Y
core +1 more source
Evaluation of Rivaroxaban- and Dabigatran-Associated Hemorrhagic Events Using the FDA-Adverse Event Reporting System Database (FAERS) [PDF]
Mingxing Guo +7 more
openalex +1 more source
Detection and analysis of the safety profile of talazoparib based on FAERS database
Talazoparib was approved for the treatment of breast cancer. However, the safety of talazoparib in a large population sample over an extended period remained uncertain. The objective of this study is to offer guidance for the secure utilization of talazoparib in clinical settings.
Mufei Tang +5 more
openaire +2 more sources

